Visanji, Naomi P.

Gastrointestinal Dysfunction in Parkinson’s Disease

Fasano, A., Visanji, N. P., Liu, L. W. C., Lang, A. E., & Pfeiffer, R. F. (2015) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 1,016

The prion hypothesis in Parkinson's disease: braak to the future

Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 278

Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations

Huot, P., Johnston, T. H., Darr, T., Hazrati, L., Visanji, N. P., Pires, D., Brotchie, J. M., & Fox, S. H. (2010) · Movement Disorders

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 153

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson’s disease

Kim, K. S., Marcogliese, P. C., Yang, J., Callaghan, S. M., Resende, V., Abdel-Messih, E., Marras, C., Visanji, N. P., Huang, J., Schlossmacher, M. G., et al. (2018) · Proceedings of the National Academy of Sciences

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 111

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

Martinez-Valbuena, I., Visanji, N. P., Kim, A., Lau, H. H. C., So, R. W. L., Alshimemeri, S., Gao, A., Seidman, M. A., Luquin, M. R., Watts, J. C., et al. (2022) · Translational Neurodegeneration

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 103

Tumor Necrosis Factor‐α Underlies Loss of Cortical Dendritic Spine Density in a Mouse Model of Congestive Heart Failure

Meissner, A., Visanji, N. P., Momen, M. A., Feng, R., Francis, B. M., Bolz, S., & Hazrati, L. (2015) · Journal of the American Heart Association

Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Cited by 56

Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

Visanji, N. P., Mitchell, S. N., O'Neill, M. J., & Duty, S. (2006) · Neuropharmacology

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 25